Position in ARVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,543,508
+$1,640,851 QoQ
Shares Held
426,415
+137.6% QoQ
Ownership
0.652%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#30
of 201 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. ARVN ranks #53 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in ARVN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,543,508 | 426,415 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,902,657 | 179,496 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,313,126 | 195,036 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,073,137 | 243,326 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,572,045 | 892,941 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,256,346 | 463,867 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,948,789 | 205,988 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,139,342 | 168,061 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,183,205 | 44,448 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,989,489 | 48,195 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,069,342 | 74,571 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,405,929 | 173,418 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,958,270 | 119,189 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,320,976 | 48,352 | Shares | Sole | 2023-05-12 | |
| 2020-06-30 | $493,373 | 14,710 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,042,762 | 25,875 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||